S6925 | Relates to capping cost sharing for antiviral COVID-19 therapeutics | Smith & MosesOfficial Title
Relates to capping cost sharing for antiviral COVID-19 therapeutics
2025-2026 SessionBrad Hoylman-SigalAffects: Insurance Law Status
In Senate Committee
Insurance
Impact Rating
Unable to calculate
Passage Likelihood
Unable to calculate